Zessin, A. S., Randall, A., McCall, S., Datto, M. B., & Hsu, S. D. (2014). Identification and validation of actionable mutations in solid tumors. In Journal of Clinical Oncology (Vol. 32, pp. e22149–e22149). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2014.32.15_suppl.e22149

Zessin, Amelia S., Adrian Randall, Shannon McCall, Michael B. Datto, and Shiaowen David Hsu. “Identification and validation of actionable mutations in solid tumors.” In Journal of Clinical Oncology, 32:e22149–e22149. American Society of Clinical Oncology (ASCO), 2014. https://doi.org/10.1200/jco.2014.32.15_suppl.e22149.

Zessin AS, Randall A, McCall S, Datto MB, Hsu SD. Identification and validation of actionable mutations in solid tumors. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014. p. e22149–e22149.

Zessin, Amelia S., et al. “Identification and validation of actionable mutations in solid tumors.” Journal of Clinical Oncology, vol. 32, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2014, pp. e22149–e22149. Crossref, doi:10.1200/jco.2014.32.15_suppl.e22149.

Zessin AS, Randall A, McCall S, Datto MB, Hsu SD. Identification and validation of actionable mutations in solid tumors. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014. p. e22149–e22149.